Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Believes the Stern-Controlled Board’s Decision to Challenge Our Special Meeting Demand – Without Any Valid Justification – Reinforces the Need for Objective and Independent Perspectives in the BoardroomContends the Company is Making Misleading Claims About Murchinson to Distract from Mr. Stern Having Presided Over a...
Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) for critical care indications, announced today their participation in two January conferences, Advanced
Athersys Provides MultiStem Clinical Update - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- The "Regenerative Medicines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
/PRNewswire/ -- The "Regenerative Medicines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...